NIH Funding Opportunities
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 9 min ago
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network (NCTN)(U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-20-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits renewal applications for Biobanks that will support the following NCI clinical trial programs: The NCI National Clinical Trials Network (NCTN; https://research.usc.edu/nci-national-clinical-trials-network-nctn-program/), and NCI Community Oncology Research Program (NCORP). The NCTN Biospecimen Bank (also referred to as NCTN Biobanks) will be responsible for collecting, processing, storing, and distributing well-annotated human specimens from patients with cancer who are participating in NCI-funded NCTN Phase II-III and other clinical treatment trials (CTEP/Division of Cancer Treatment and Diagnosis; DCTD). The main goal is to support NCTN with the state-of the-art banking infrastructure and operations including maintenance of up-to-date specimen inventory. The NCTN Biobanks will distribute to qualified investigators the biospecimens linked to high-quality clinical data (including treatment and outcome information) that are critical for developing and validating biomarkers for cancer diagnosis, prognosis and prediction of responses to therapy. The NCTN Biobanks will work in collaboration with NCTN Groups and Group Statistical and Data Management Centers as well as affiliated institutions to ensure effective operation. Each Biobank needs to maintain association with one specific NCTN Group and needs to be endorsed in that role by the group leaders. NCTN Biobanks will also support biobanking and storage of biospecimens from NCORP cancer control and prevention trials (NCORP/Division of Cancer Prevention; DCP).
Notice of Special Interest - Administrative Supplements for Regulatory Support for SBIR/STTR Awardees
Notice NOT-AA-19-029 from the NIH Guide for Grants and Contracts
Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional)
Funding Opportunity PAR-20-036 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support grants to improve understanding of viral suppression and HIV transmission in the United States (U.S.) using population-level epidemiology, novel tools from data science approaches and m/eHealth, and implementation science research. Data generated through this research will be used to inform and evaluate context-specific HIV control strategies towards the goal of ending the HIV epidemic in the U.S.
Funding Opportunity PAR-20-042 from the NIH Guide for Grants and Contracts. The National Center for Medical Rehabilitation Research (NCMRR) Early Career Research (ECR) Award (R03) is intended to support both basic and clinical research from rehabilitation scientists who are establishing independent research careers. The research must be focused on one or more of the areas within the biomedical and behavioral mission of NCMRR: pathophysiology and management of chronically injured nervous and musculoskeletal systems (including stroke, traumatic brain injury, spinal cord injury, and orthopedic conditions); repair and recovery of motor and cognitive function; functional plasticity, adaptation, and windows of opportunity for rehabilitative interventions; rehabilitative strategies involving pharmaceutical, stimulation, and neuroengineering approaches, exercise, motor training, and behavioral modifications; pediatric rehabilitation; secondary conditions associated with chronic disabilities; improved diagnosis, assessment, and outcome measures; and development of orthotics, prosthetics, and other assistive technologies and devices. The NCMRR ECR Award R03 grant mechanism supports different types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; translational research; outcomes research; and development of new technology. Irrespective of the type of project, the intent of the NCMRR ECR Award R03 is for the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) to obtain sufficient preliminary data for a subsequent R01 application.
Identification, Validation, and Manipulation of Neural Circuits Related to Mental Illness and Alcohol and Substance Use Disorders in Non-human Primates (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-MH-20-320 from the NIH Guide for Grants and Contracts. The goal of this initiative is to support the identification, validation and manipulation of neural circuits that underlie cognitive, emotional, and social processes impacted in mental illnesses including alcohol use disorder and other substance abuse. The initiative is focused on probing circuit mechanisms underlying neuro-psychiatrically relevant behavior through studies in non-human primates. This initiative is intended to complement existing institute-funded preclinical investigation of circuits which have often focused on smaller brains.
Request for Information (RFI) on Next Directions for the National Library of Medicines Unified Medical Language System
Notice NOT-LM-20-001 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AG-20-027 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for research and development to improve functioning and quality of life for the elderly, especially the disabled elderly, living in low- and middle-income countries (LMICs), or to improve functioning and quality of life for low-income, disabled, and isolated elderly living in high-income countries. Applications may address the needs of the elderly directly or indirectly by supporting family or other informal caregivers and service providers. Applications likely to have an impact on a large scale are encouraged.
Funding Opportunity RFA-TR-20-001 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research to address ethical issues in translational science research. Collaboration between bioethicists, legal scholars, social scientists, and translational research scientists is encouraged. The focus is to develop knowledge to inform the ethical development, modification, or application of novel findings, technologies, and approaches to improve human health, including their impact on individuals, families, communities, and society.
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trials Optional)
Funding Opportunity RFA-AG-20-026 from the NIH Guide for Grants and Contracts. The overall goal of this FOA is to support the development of a collaborative research and resource network to synergize the expertise, skills, and resources of investigators within the geriatric emergency medicine and Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) research communities to identify and address research gaps towards optimizing recognition and emergency care of older adults with AD/ADRD.
Notice of Correction to RFA-CA-19-052, "Revision Applications for Mechanisms of Cancer Drug Resistance (P01 Clinical Trial Not Allowed)"
Notice NOT-CA-20-003 from the NIH Guide for Grants and Contracts
Notice NOT-CA-20-004 from the NIH Guide for Grants and Contracts
Notice NOT-AR-20-005 from the NIH Guide for Grants and Contracts
Notice of Intent to Publish a Funding Opportunity Announcement for a Coordinating Center for Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry (U01 Clinical Trial Not Allowed)
Notice NOT-HG-20-006 from the NIH Guide for Grants and Contracts
Notice of Intent to Publish a Funding Opportunity Announcement for Centers for Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry (U01 Clinical Trial Not Allowed)
Notice NOT-HG-20-005 from the NIH Guide for Grants and Contracts
NIA Intervention Testing Program (ITP) Announces Annual Call for Compounds to Test for Anti-Aging Activity in Mice
Notice NOT-AG-20-003 from the NIH Guide for Grants and Contracts
Notice Extending Expiration Date and Adding Receipt Date for PAR-15-352: Occupational Safety and Health Training Project Grants (T03)
Notice NOT-OH-20-002 from the NIH Guide for Grants and Contracts
Notice Extending Expiration Date and Adding Receipt Date for PAR-15-303: Occupational Safety and Health Education and Research Centers (T42)
Notice NOT-OH-20-001 from the NIH Guide for Grants and Contracts
The NIH Office of Disease Prevention (ODP) Announces the Pathways to Prevention Workshop: Can Physical Activity Improve the Health of Wheelchair Users?
Notice NOT-OD-20-010 from the NIH Guide for Grants and Contracts
Notice of Special Interest: Notice of Availability of Administrative Supplements for Short-term Research Career Enhancement in Genomics for Experienced Investigators
Notice NOT-HG-19-025 from the NIH Guide for Grants and Contracts
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-021 from the NIH Guide for Grants and Contracts. (Reissue of PAR-16-458) The purpose of this award is to support outstanding scientific training of highly promising postdoctoral candidates with outstanding mentors. Candidates are eligible to apply for support from this program from ~12 months prior to the start of the proposed postdoctoral position to within 12 months after starting in postdoctoral position. Based on the early timeframe of eligibility, and the discouragement of inclusion of preliminary data, this NINDS F32 seeks to foster early, goal-directed planning and to encourage applications for bold and/or innovative projects by the candidate that have the potential for significant impact. Applications are expected to incorporate strong training in quantitative reasoning and the quantitative principles of experimental design and analysis. Support by this program is limited to the first 3 years of a candidate's activity in a specific laboratory or research environment, so as to further encourage early fellowship application and timely completion of mentored training of the postdoctoral candidate in a single environment.
NIH Funding Opportunities
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Notice to Withdraw the Centers for Disease Control and Prevention (CDC) as a Participating Organization from PAR-19-334 entitled "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed"
- Notice of Special Interest (NOSI): Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project
- Notice of Special Interest (NOSI): Mentored Career Development Awards to Foster the Careers of Investigators Pursuing Research Related to Down syndrome as Part of the INCLUDE Project
- Reminder of application instructions and policies impacting SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance PAR-19-333, PAR-19-334, and PAR-19-335